SD5

5-[2,6-di(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine

Created:	2011-06-14
Last modified:	2011-06-14

Find Related PDB Entry
3 entries where SD5 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	50
Chiral Atom Count	0
Bond Count	53
Aromatic Bond Count	12

2D diagram of SD5

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-[2,6-di(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine
Systematic Name (OpenEye OEToolkits)	5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
Formula	C₁₈ H₂₁ F₃ N₆ O₂
Molecular Weight	410.394
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	FC(F)(F)c1cc(ncc1c3nc(nc(N2CCOCC2)c3)N4CCOCC4)N
SMILES	CACTVS	3.370	Nc1cc(c(cn1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
SMILES	OpenEye OEToolkits	1.7.2	c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
Canonical SMILES	CACTVS	3.370	Nc1cc(c(cn1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
Canonical SMILES	OpenEye OEToolkits	1.7.2	c1c(c(cnc1N)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
InChI	InChI	1.03	InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)
InChIKey	InChI	1.03	CWHUFRVAEUJCEF-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB11666
Name	Buparlisib
Groups	investigational
Description	Buparlisib has been used in trials studying the treatment and basic science of Lymphoma, Metastases, Lung Cancer, Solid Tumors, and Breast Cancer, among others.
Synonyms	Buparlisibum Buparlisib Buparlisib hydrochloride
Categories	Amines Oxazines Phosphatidylinositol 3-Kinases, antagonists & inhibitors Pyridines
CAS number	944396-07-0

Related Resource References

Resource Name	Reference
Pharos	CHEMBL2017974
PubChem	16654980
ChEMBL	CHEMBL2017974
ChEBI	CHEBI:71954

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.